198 related articles for article (PubMed ID: 30301882)
1. Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance.
Kumar S; Talluri S; Pal J; Yuan X; Lu R; Nanjappa P; Samur MK; Munshi NC; Shammas MA
Blood Cancer J; 2018 Sep; 8(10):92. PubMed ID: 30301882
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the involvement of apurinic/apyrimidinic endonuclease 1 in the resistance to melphalan in multiple myeloma.
Xie J; Zhang L; Li M; Du J; Zhou L; Yang S; Zeng L; Li Z; Wang G; Wang D
BMC Cancer; 2014 Jan; 14():11. PubMed ID: 24400589
[TBL] [Abstract][Full Text] [Related]
3. miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1.
Yuan X; Ma R; Yang S; Jiang L; Wang Z; Zhu Z; Li H
Cell Cycle; 2019 Jul; 18(14):1660-1669. PubMed ID: 31204563
[No Abstract] [Full Text] [Related]
4. A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment.
Alagpulinsa DA; Yaccoby S; Ayyadevara S; Shmookler Reis RJ
Cancer Biol Ther; 2015; 16(6):976-86. PubMed ID: 25996477
[TBL] [Abstract][Full Text] [Related]
5. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.
Tomasi ML; Iglesias-Ara A; Yang H; Ramani K; Feo F; Pascale MR; Martínez-Chantar ML; Mato JM; Lu SC
Gastroenterology; 2009 Mar; 136(3):1025-36. PubMed ID: 18983843
[TBL] [Abstract][Full Text] [Related]
6. Mild phenotype of knockouts of the major apurinic/apyrimidinic endonuclease APEX1 in a non-cancer human cell line.
Kim DV; Kulishova LM; Torgasheva NA; Melentyev VS; Dianov GL; Medvedev SP; Zakian SM; Zharkov DO
PLoS One; 2021; 16(9):e0257473. PubMed ID: 34529719
[TBL] [Abstract][Full Text] [Related]
7. In vitro evidence for homologous recombinational repair in resistance to melphalan.
Wang ZM; Chen ZP; Xu ZY; Christodoulopoulos G; Bello V; Mohr G; Aloyz R; Panasci LC
J Natl Cancer Inst; 2001 Oct; 93(19):1473-8. PubMed ID: 11584063
[TBL] [Abstract][Full Text] [Related]
8. Experimental study enhancing the chemosensitivity of multiple myeloma to melphalan by using a tissue-specific APE1-silencing RNA expression vector.
Yang ZZ; Chen XH; Wang D
Clin Lymphoma Myeloma; 2007 Jan; 7(4):296-304. PubMed ID: 17324338
[TBL] [Abstract][Full Text] [Related]
9. Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.
Spanswick VJ; Lowe HL; Newton C; Bingham JP; Bagnobianchi A; Kiakos K; Craddock C; Ledermann JA; Hochhauser D; Hartley JA
BMC Cancer; 2012 Sep; 12():436. PubMed ID: 23020514
[TBL] [Abstract][Full Text] [Related]
10. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.
Sousa MM; Zub KA; Aas PA; Hanssen-Bauer A; Demirovic A; Sarno A; Tian E; Liabakk NB; Slupphaug G
PLoS One; 2013; 8(2):e55493. PubMed ID: 23405159
[TBL] [Abstract][Full Text] [Related]
11. The role of the N-terminal domain of human apurinic/apyrimidinic endonuclease 1, APE1, in DNA glycosylase stimulation.
Kladova OA; Bazlekowa-Karaban M; Baconnais S; Piétrement O; Ishchenko AA; Matkarimov BT; Iakovlev DA; Vasenko A; Fedorova OS; Le Cam E; Tudek B; Kuznetsov NA; Saparbaev M
DNA Repair (Amst); 2018 Apr; 64():10-25. PubMed ID: 29475157
[TBL] [Abstract][Full Text] [Related]
12. ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma.
Kumar S; Talluri S; Zhao J; Liao C; Potluri LB; Buon L; Mu S; Shi J; Chakraborty C; Tai YT; Samur MK; Munshi NC; Shammas MA
Blood; 2024 Mar; 143(11):996-1005. PubMed ID: 37992230
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
14. Induction of chemoresistance by all-trans retinoic acid via a noncanonical signaling in multiple myeloma cells.
Liu Z; Li T; Jiang K; Huang Q; Chen Y; Qian F
PLoS One; 2014; 9(1):e85571. PubMed ID: 24416428
[TBL] [Abstract][Full Text] [Related]
15. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
Kim KY; Han W; Noh DY; Kang D; Kwack K
Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
[TBL] [Abstract][Full Text] [Related]
16. Genetic and expressional variations of APEX1 are associated with increased risk of head and neck cancer.
Mahjabeen I; Baig RM; Sabir M; Kayani MA
Mutagenesis; 2013 Mar; 28(2):213-8. PubMed ID: 23408843
[TBL] [Abstract][Full Text] [Related]
17. CiApex1 has AP endonuclease activity and abrogated AP site repair disrupts early embryonic development in Ciona intestinalis.
Igarashi K; Funakoshi M; Kato S; Moriwaki T; Kato Y; Zhang-Akiyama QM
Genes Genet Syst; 2019 Apr; 94(2):81-93. PubMed ID: 30930342
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of CD98 in melphalan-resistant myeloma cells with reduced drug uptake.
Harada N; Nagasaki A; Hata H; Matsuzaki H; Matsuno F; Mitsuya H
Acta Haematol; 2000; 103(3):144-51. PubMed ID: 10940652
[TBL] [Abstract][Full Text] [Related]
19. Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma.
Ströbel T; Madlener S; Tuna S; Vose S; Lagerweij T; Wurdinger T; Vierlinger K; Wöhrer A; Price BD; Demple B; Saydam O; Saydam N
Sci Rep; 2017 Aug; 7(1):9674. PubMed ID: 28852018
[TBL] [Abstract][Full Text] [Related]
20. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
